US 11,666,554 B2
Use of a carbamate compound to prevent, alleviate or treat visceralgia or pain arising from visceral disease
Han Ju Yi, Gyeonggi-do (KR)
Assigned to SK BIOPHARMACEUTICALS CO., LTD., Gyeonggi-do (KR)
Appl. No. 16/763,751
Filed by SK BIOPHARMACEUTICALS CO., LTD., Gyeonggi-do (KR)
PCT Filed Nov. 13, 2018, PCT No. PCT/KR2018/013768
§ 371(c)(1), (2) Date May 13, 2020,
PCT Pub. No. WO2019/098633, PCT Pub. Date May 23, 2019.
Claims priority of application No. 10-2017-0151256 (KR), filed on Nov. 14, 2017.
Prior Publication US 2020/0368203 A1, Nov. 26, 2020
Int. Cl. A61K 31/41 (2006.01); A61P 29/00 (2006.01)
CPC A61K 31/41 (2013.01) [A61P 29/00 (2018.01)] 7 Claims
 
1. A method for alleviating or treating visceral pain or pain caused by visceral diseases in a subject, comprising administering a therapeutically effective amount of a carbamate compound of the following Formula 1, or a pharmaceutically acceptable salt, solvate or hydrate thereof to the subject:

OG Complex Work Unit Chemistry
wherein,
R1 and R2 are each independently selected from the group consisting of hydrogen, halogen, and C1-C8 alkyl; and
one of A1 and A2 is CH, and the other is N.